Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug

Plus, news about Jasper, AbbVie, Belite Bio and Axoltis Pharma: ✂️ Pfizer ends work on ulcerative colitis asset: The big pharma axed a Phase 1 contender called PF-07899895 “due to a business decision,” according ...